Myriad Genetics Inc (MYGN)
Gross profit margin
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross profit (ttm) | US$ in thousands | 116,700 | 33,100 | 3,900 | -190,500 | -127,800 | 17,200 | 96,500 | 317,700 | 274,600 | 254,600 | 231,400 | 100 | 11,000 | -97,900 | -65,600 | -36,200 | 43,500 | 185,500 | 206,900 | 230,000 |
Revenue (ttm) | US$ in thousands | 794,900 | 766,400 | 745,400 | 731,500 | 696,200 | 691,900 | 675,200 | 820,600 | 831,200 | 839,900 | 846,300 | 666,200 | 590,100 | 564,400 | 586,600 | 627,900 | 750,000 | 801,700 | 822,500 | 840,100 |
Gross profit margin | 14.68% | 4.32% | 0.52% | -26.04% | -18.36% | 2.49% | 14.29% | 38.72% | 33.04% | 30.31% | 27.34% | 0.02% | 1.86% | -17.35% | -11.18% | -5.77% | 5.80% | 23.14% | 25.16% | 27.38% |
June 30, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $116,700K ÷ $794,900K
= 14.68%
Myriad Genetics Inc's gross profit margin has displayed significant fluctuations over the past few quarters. The company experienced a sharp increase in its gross profit margin from December 2022 to March 2023, reaching 14.29%. However, this positive trend was short-lived as the margin dropped to 2.49% in June 2023, indicating a notable decline in profitability.
Subsequently, the company faced challenges in maintaining a healthy gross profit margin, with negative margins recorded in September 2023 and December 2023 at -26.04% and 0.52% respectively. This suggests that the company's cost of goods sold exceeded its revenues during these periods, impacting profitability.
The financial performance improved in the first half of 2024, with a gross profit margin of 4.32% in March 2024 and a further increase to 14.68% in June 2024. While these figures show a positive trajectory, they are still relatively low compared to historical levels.
Overall, the fluctuating trend in Myriad Genetics Inc's gross profit margin indicates volatility in the company's ability to generate profits from its core operations. It is imperative for the company to closely monitor and manage its cost structure and pricing strategies to enhance profitability and ensure sustainable performance in the future.
Peer comparison
Jun 30, 2024